Special Issue "Nutrition and Liver Disease"
A special issue of Nutrients (ISSN 2072-6643).
Deadline for manuscript submissions: closed (30 September 2014)
Dr. Leanne Hodson
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford Churchill Hospital, Headington OX3 7LE, UK
The liver is the chief metabolic visceral organ that performs a vast range of different functions that including: metabolism of lipids, carbohydrates, and vitamins. In humans, diseases of the liver are a global public health issue and burden and non-alcoholic fatty liver disease (NAFLD), is one of the most prevalent liver diseases in developed countries. NAFLD represents a spectrum of conditions ranging from simple fatty liver (hepatic steatosis) through to severe liver disease such as cirrhosis and potentially hepatocellular carcinoma (HCC). Dietary patterns, for example overconsumption of dietary fat and carbohydrate, along with specific dietary components have all been implicated in the initiation and progression of liver disease.
Dr. Leanne Hodson
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed Open Access monthly journal published by MDPI.
- dietary intake
- non-alcoholic fatty liver disease (NAFLD)